Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,519 | -5,576 | -12,543 | -31,608 | -12,768 |
| Depreciation Amortization | 7 | 4 | 10 | 7 | 19 |
| Accounts receivable | N/A | N/A | 1,481 | N/A | 2,246 |
| Accounts payable and accrued liabilities | -1,167 | 334 | -2,256 | 1,313 | -311 |
| Other Working Capital | -1,046 | 772 | -968 | 2,370 | 2,035 |
| Other Operating Activity | 9,898 | -60 | 1,430 | 10,324 | -1,421 |
| Operating Cash Flow | $-4,827 | $-4,525 | $-12,846 | $-17,595 | $-10,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -577 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 1,342 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,500 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1,500 | 0 |
| Investing Cash Flow | $765 | $N/A | $N/A | $-1,500 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,560 | 1,527 | 6,921 | 1,987 | 28,773 |
| Other Financing Activity | -222 | -467 | -281 | 0 | -477 |
| Financing Cash Flow | $12,338 | $1,060 | $6,640 | $1,987 | $28,296 |
| Beginning Cash Position | 2,435 | 5,900 | 12,106 | 29,214 | 11,119 |
| End Cash Position | 10,710 | 2,435 | 5,900 | 12,106 | 29,214 |
| Net Cash Flow | $8,275 | $-3,465 | $-6,207 | $-17,108 | $18,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,827 | -4,525 | -12,846 | -17,595 | -10,200 |
| Capital Expenditure | -577 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -5,404 | -4,525 | -12,846 | -17,595 | -10,200 |